Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M666Revenue $M38.8Net Margin (%)-241.9Altman Z-Score-4.0
Enterprise Value $M516EPS $-0.4Operating Margin %-270.9Piotroski F-Score2
P/E(ttm)--Beneish M-Score-2.9Pre-tax Margin (%)-241.9Higher ROA y-yN
Price/Book6.310-y EBITDA Growth Rate %-29.6Quick Ratio3.6Cash flow > EarningsN
Price/Sales16.35-y EBITDA Growth Rate %-45.7Current Ratio3.8Lower Leverage y-yY
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)-29.3Higher Current Ratio y-yN
Dividend Yield %--PEG--ROE % (ttm)-101.4Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M242ROIC % (ttm)--Gross Margin Increase y-yN

Gurus Latest Trades with ARNA

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
Current Price Change from Average Comment Current Shares
ARNAKen Fisher 2013-12-31 Buy $4.08 - $6.66
$ 2.75-47%New holding11,000
ARNAMario Gabelli 2011-03-31 Sold Out $1.41 - $2.16
$ 2.7562%Sold Out0
ARNAMario Gabelli 2010-12-31 Buy $1.27 - $2.38
$ 2.7574%New holding13,000
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

ARNA is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!

ARNA: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
WOODS RANDALL EDirector 2015-03-30Sell76,268$4.49-39.87view
SPECTOR STEVEN WEVP, General Counsel & Sec 2015-03-17Sell70,000$5-46view
SPECTOR STEVEN WEVP, General Counsel & Sec 2015-01-08Sell45,000$6.26-56.87view
SHANAHAN WILLIAM R JRSVP & Chief Medical Officer 2015-01-07Sell50,000$5.49-50.82view
LIEF JACKChairman, President and CEO 2014-07-01Sell223,525$5.85-53.85view
BELCHER DONALD DDirector 2014-06-27Sell2,473$5.85-53.85view
SPECTOR STEVEN WEVP, General Counsel & Sec 2014-05-12Sell45,000$7.05-61.7view
BELCHER DONALD DDirector 2014-05-06Sell4,176$7-61.43view
HIXSON HARRY F JRDirector 2014-04-22Sell36,900$6.31-57.21view
Nova Tina SusanDirector 2014-04-14Sell35,000$6.22-56.59view

Quarterly/Annual Reports about ARNA:

    News about ARNA:

    Articles On GuruFocus.com
    Revisiting Arena, Orexigen, And VIVUS: Shareholders Can Recoup Their Losses By Invest In MannKind Aug 19 2014 
    (ARNA) Initiated with a Buy, (ICLD, FONR) Strong Performance on Financial Results Nov 16 2013 
    comment on ARNA Mar 15 2013 
    comment on ARNA Mar 02 2013 
    Arena Facing Increased Pressure from Peers Apr 23 2012 
    Arena Could Dip If Lorcaserin Fails Again Apr 22 2012 
    Vivus Could Rocket on Success of Qnexa Apr 13 2012 
    These 4 Biotech Stocks Are a Buy Now Feb 08 2012 

    More From Other Websites
    M argaret Court Arena receives LEED Gold certification Sep 01 2015
    Westaim Completes Arena Transactions Aug 31 2015
    Westaim completes Arena Transactions Aug 31 2015
    Arena's Cloud PLM Integrates With Kenandy's Cloud ERP Aug 27 2015
    Arena Pharmaceuticals (ARNA) Rises: Stock Adds 5.7% in Session Aug 24 2015
    ARENA PHARMACEUTICALS INC Financials Aug 20 2015
    Arena Solutions Partners with GoodData to Create Arena Analytics Aug 18 2015
    Arena-JOGMEC JV Approves a USD$2.7M-12,600 Metre Drill Program on Atacama Copper Project Aug 18 2015
    Connected Philips LED lighting for the Allianz Arena: FC Bayern Munich kicks off the season with... Aug 13 2015
    Medical Device Companies Embrace Arena's Cloud-Based PLM Solution Aug 11 2015
    10-Q for Arena Pharmaceuticals, Inc. Aug 09 2015
    Biotech Stock Mailbag: Controversial Stocks Revisited Aug 07 2015
    Arena Pharmaceuticals 2Q Loss Narrower-Than-Expected - Analyst Blog Aug 06 2015
    Edited Transcript of ARNA earnings conference call or presentation 5-Aug-15 9:00pm GMT Aug 05 2015
    Arena Pharmaceuticals reports 2Q loss Aug 05 2015
    Arena Pharmaceuticals reports 2Q loss Aug 05 2015

    Add Notes, Comments

    If you want to ask a question or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)